# CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

> **NCT06937567** · EARLY_PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 18 (estimated)

## Conditions studied

- Biliary Tract Cancer
- Colorectal Carcinoma
- Gastric Cancer, Metastatic
- Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
- Multiple Cancer

## Interventions

- **BIOLOGICAL:** CDH17 CAR-T

## Key facts

- **NCT ID:** NCT06937567
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-26
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937567, "CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06937567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*